Aprea Therapeutics Inc (APRE)
3.972
+0.05
(+1.32%)
USD |
NASDAQ |
Nov 04, 16:00
4.06
+0.09
(+2.22%)
Pre-Market: 20:00
Aprea Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Aethlon Medical Inc | -- |
| Brainstorm Cell Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 29.96M |
| Total Liabilities (Quarterly) | 4.405M |
| Shareholders Equity (Quarterly) | 25.56M |